Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 699 Shares of Stock
Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 699 shares of Varian Medical Systems stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $126.47, for a total value of $88,402.53. Following the transaction, the executive vice president now directly owns 27,361 shares in the company, valued at $3,460,345.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Varian Medical Systems, Inc. (NYSE VAR) opened at $125.49 on Wednesday. Varian Medical Systems, Inc. has a 1 year low of $87.49 and a 1 year high of $130.29. The firm has a market capitalization of $11,480.00, a price-to-earnings ratio of 34.38, a P/E/G ratio of 3.67 and a beta of 0.85.
Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The business had revenue of $678.50 million during the quarter, compared to analyst estimates of $633.96 million. During the same quarter last year, the company posted $1.09 EPS. Varian Medical Systems’s revenue for the quarter was up 12.8% on a year-over-year basis. equities research analysts expect that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current year.
A number of research analysts recently issued reports on VAR shares. TheStreet lowered Varian Medical Systems from a “b+” rating to a “c” rating in a report on Monday, February 12th. Evercore ISI started coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 target price on the stock. Zacks Investment Research raised Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Monday, January 29th. ValuEngine raised Varian Medical Systems from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, JPMorgan Chase & Co. increased their price target on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $111.80.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.